University of Zurich

Lead scientists: Milo Puhan, Jan Fehr, Susi Kriemler

At the Epidemiology Biostatistics and Prevention Institute (EBPI) we improve, implement, and teach best practice research methods, providing evidence and context for informed health decisions. The EBPI’s four, closely-linked major areas of activity bridge teaching and training to evidence-based health care and public health services. Approximately 250 employees work at the EBPI, which is part of the Faculty of Medicine and the Faculty of Science at the University of Zurich.

Three prospective cohort studies based at the EBPI contribute to the CoVICIS project: Ciao Corona (2500 children and adolescents), Zurich Corona Virus Cohort study (1500 persons enrolled at time of infection) and Zurich Vaccination Cohort Study (600 persons enrolled at time of vaccination). These three studies contribute to the Corona Immunitas research program, which is based at the Swiss School of Public Health SSPH+ and includes more than 40 cross-sectional and longitudinal studies conducted by 14 Swiss universities.

Furthermore, there is a performance mandate for the reference COVID 19 vaccination center and for running Prevention & Health Promotion of the Government Council of the Canton of Zurich. On a national level, we collaborate with other Swiss universities and contribute to Masters and PhD programs at the Swiss School of Public Health SSPH+. Our graduate training programs (PhD program in Epidemiology and Biostatistics and Masters in Biostatistics) attract high caliber students from all over the world. Prof Dr. med et phil. Milo Puhan is Director of the EBPI.

Roles in the COVICS project:
  • Contribution to the cohort studies on targeted population (WP3)
  • Co-Lead of WP4 Children Cohort

CoVICIS is funded by the European Union’s Horizon Europe Research and Innovation Programme under grant nr 101046041